India aims for at least 1,500 biotech start-ups

Image
IANS Kolkata
Last Updated : Nov 13 2015 | 2:22 PM IST

India aims to scale up start-ups in the biotechnology sector to at least 1,500 in the next two to three years to boost technological interventions in the health and agriculture sectors, a senior biotechnology department official said.

"We presently have around 500 start-ups in the biotech sector. It is less in comparison with other sectors. We plan to scale it up to 1,500 to 2,000 in the next two to three years," said Renu Swarup, department of biotechnology's senior adviser and managing director of the Biotechnology Industry Research Assistance Council (BIRAC).

She pointed out that there was a growing market for biotech products and services given India's population and its needs.

Biotech start-ups are into bio-pharma (diagnostics and therapeutics), agricultural (biofertilisers, hybrid seeds etc.), bioinformatics and drug development, etc.

"They are directly or indirectly linked to the health and agricultural sectors," Swarup told IANS.

Prime Minister Narendra Modi earlier this year announced a 'Start-up India, Stand up India' campaign to promote bank financing for start-ups and offer incentives to boost entrepreneurship and job creation.

"Under the new initiative, if we can create a favourable business environment, we can tap into our own products and know-how for solutions in health and agriculture," she said.

It would also help researchers to become 'tech-preneurs'.

"We have seen good interventions happening in Odisha and Tamil Nadu," said Swarup.

The Indian biotech industry holds about two percent share of the global biotech sector. At present India is ranked 12th in the world in the biotech sector and third in the Asia-Pacific region.

By 2017, the size of India's biotech industry is estimated to increase to $11.6 billion from $4.3 billion in 2012.

Indian biotech entrepreneur Kiran Majumdar Shaw has said that the emergence of biotech start-ups is resulting in a reverse brain drain.

Currently, Swarup said, new products have emerged from the Grand Challenges India (GCI) Interventions. The GCI was jointly launched by BIRAC under the department of biotechnology and the Bill and Melinda Gates Foundation in 2013.

"These include improved sanitation technologies and bio-digester designs. Initially, they will be showcased as demonstrations on a large scale and subsequently introduced in the market," she said.

(Sahana Ghosh can be contacted at sahana.g@ians.in)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 13 2015 | 2:02 PM IST

Next Story